CABA

Conviction 70HealthcareScan · Thu, Jun 25, 2026

CABA$2.93-3.30%

ResistanceSupportVol 14

Vol MA14 5.71M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Cabaletta Bio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cabalettabio.com ↗

Price2.93

Change-3.30%

Gap+0.50%

Rel volume3.27×

Avg volume4.99M

Avg $ vol15.46M

SMA 203.21

SMA 503.34

SMA 2002.78

Price vs 50-12.32%

Price vs 200+5.31%

MA stackmixed

50/200 cross—

Supertrenddown · 3.64

RSI (14)39

MACD hist-0.02

MACD cross—

Stoch %K / %D22 / 25

ADX (14)13

+DI / −DI18 / 21

RSI divergence—

MACD divergence—

ATR %+8.25%

ADR %7.46%

52w high4.15

52w low1.33

From 52w high-29.40%

Above 52w low+120.30%

New 52w highNo

SqueezeOff

Bollinger width40.16%

%B0.28

Donchian pos13.33%

Donchian high3.97

Donchian low2.77

AVWAP (52w high)3.34

vs AVWAP high-12.40%

AVWAP (52w low)2.88

vs AVWAP low+1.91%

OBV trendDown

Chaikin MF (20)-0.42

Today vs 20d3.27×

Avg vol (14d)5.71M

Avg vol (20d)4.99M

Avg $ vol (20d)15.46M

Market cap477.75M

RS 3m (vs SPY)+1.23%

RS 6m (vs SPY)+19.04%

RS line new highNo

Trend template6/8

Technical rank50.0

1 week+3.17%

1 month-21.24%

3 months+5.40%

6 months+22.59%

1 year+65.54%

YTD+32.58%

P/E-2.85

P/B4.62

P/S—

P/FCF-3.61

EPS-2.10

Div yield—

ROE-162.49%

ROA-113.30%

Debt/Eq—

Current2.95

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-44.87%

Price target15.75

Target upside437.54%

Analyst ratingBuy

Institutional55.12%

Ent. value361.12M

Revenue—

Net income-43.52M

Gross profit—

Free cash flow-132.31M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out163.05M

Employees158

ListedFri, Oct 25, 2019

Free float105.3M

Float %94.6%

Short interest22.94M

Days to cover7.6d

Short volume56.0%

Squeeze score91 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.37 · 3 est

Last EPS vs est−$0.39 vs −$0.41

Last surprise+4.9% beat

Setup gradeB

Conviction70 / 100

Pattern quality—

Tech rank50.0 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.16

Support2.95

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CABA

All disclosures →

No recent disclosed trades by Congress in CABA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CABA · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Brun Scott C. Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
HENRIQUES RICHARD C JR Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Simon Mark Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Bollard Catherine Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Tomasello Shawn Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10

SEC filings

EDGAR filings in CABA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.